A case-control study of the interaction of fetal heart rate abnormalities, fetal growth restriction, meconium in the amniotic fluid and tachysystole, in relation to the outcome of labour.


Journal

BJOG : an international journal of obstetrics and gynaecology
ISSN: 1471-0528
Titre abrégé: BJOG
Pays: England
ID NLM: 100935741

Informations de publication

Date de publication:
02 2023
Historique:
revised: 05 08 2022
received: 10 02 2022
accepted: 29 08 2022
pubmed: 28 9 2022
medline: 11 1 2023
entrez: 27 9 2022
Statut: ppublish

Résumé

To quantify the incidence of intrapartum risk factors in labours with an adverse outcome, and compare them with the incidence of the same indicators in a series of consecutive labours without adverse outcome. Case-control study. Twenty-six maternity units in the UK. Sixty-nine labours with an adverse outcome and 198 labours without adverse outcome. Observational study. Incidence of risk factors in hourly assessments for 7 hours before birth in the two groups. A risk score combining suspected fetal growth restriction, tachysystole, meconium in the amniotic fluid and fetal heart rate abnormalities (baseline rate and variability, presence of decelerations) gave the best indication of likely outcome group. Accurate risk assessment in labour requires fetal heart rate abnormalities to be considered in context with additional intrapartum risk factors.

Identifiants

pubmed: 36164836
doi: 10.1111/1471-0528.17302
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

286-291

Informations de copyright

© 2022 John Wiley & Sons Ltd.

Références

Steer P. Has the expression ‘fetal distress’ outlived its usefulness? Br J Obs Gynaecol. 1982;89:690-3.
Beard RW, Filshie GM, Knight CA, Roberts GM. The significance of the changes in the continuous foetal heart rate in the first stage of labour. J Obstet Gynaecol Br Commonw. 1971;78:865-81.
Alfirevic Z, Devane D, Gyte GM, Devane D. Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour. Cochrane Database Syst Rev. 2017;2:CD006066.
ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists, Number 70, December 2005 (Replaces Practice Bulletin Number 62, May 2005). Intrapartum fetal heart rate monitoring. Obstet Gynecol. 2005;106:1453-60. https://doi.org/10.1097/00006250-200512000-00053
NICE. Intrapartum care: care of healthy women and their babies during childbirth. Clinical guideline 190 (updated 2017). 2014. [cited 2021 Oct 29]. Available from: https://www.nice.org.uk/guidance/cg190
Ayres-De-Campos D, Spong CY, Chandraharan E. FIGO consensus guidelines on intrapartum fetal monitoring: cardiotocography. Int J Gynecol Obstet. 2015;131:13-24. https://doi.org/10.1016/j.ijgo.2015.06.020
Chandraharan E, Evans S, Krueger D, Pereira S, Skivens S, Zaima A. Intrapartum fetal monitoring guideline. Physiol CTG Interpret. 2018;2018:1-33.
Zamora del Pozo C, Chóliz Ezquerro M, Mejía I, de Terán Martínez-Berganza ED, Esteban LM, Alonso AR, et al. Diagnostic capacity and interobserver variability in FIGO, ACOG, NICE and Chandraharan cardiotocographic guidelines to predict neonatal acidemia. J Matern Neonatal Med. 2021;1-9. Online ahead of print. URL: https://doi.org/10.1080/14767058.2021.1986479
RCOG. Each Baby Counts; 2017. Available from: https://www.rcog.org.uk/eachbabycounts
Brocklehurst P, Field D, Greene K, Juszczak E, Keith R, Kenyon S, et al. Computerised interpretation of fetal heart rate during labour (INFANT): a randomised controlled trial. Lancet. 2017;389:1719-29.
Steer PJ, Kovar I, McKenzie C, Griffin M, Linsell L. Computerised analysis of intrapartum fetal heart rate patterns and adverse outcomes in the INFANT trial. BJOG. 2019;126:1354-61.
Khalil AA, Morales-Rosello J, Morlando M, Hannan H, Bhide A, Papageorghiou A, et al. Is fetal cerebroplacental ratio an independent predictor of intrapartum fetal compromise and neonatal unit admission? Am J Obstet Gynecol. 2015;213:54.e1-e10. https://doi.org/10.1016/j.ajog.2014.10.024
Eden RD, Evans MI, Britt DW, Evans SM, Schifrin BS. Safely lowering the emergency Cesarean and operative vaginal delivery rates using the Fetal Reserve Index. J Matern Neonatal Med. 2020;33:1473-9. https://doi.org/10.1080/14767058.2018.1519799
Steer P. The management of large and small for gestational age fetuses. Semin Perinatol. 2004;28:59-66.
Madden JV, Flatley CJ, Kumar S. Term small-for-gestational-age infants from low-risk women are at significantly greater risk of adverse neonatal outcomes. Am J Obstet Gynecol. 2018;218:525 e9.
Balchin I, Whittaker JC, Lamont RF, Steer PJ. Maternal and fetal characteristics associated with meconium-stained amniotic fluid. Obstet Gynecol. 2011;117:828-35. https://doi.org/10.1097/AOG.0b013e3182117a26
Steer PJ, Eigbe F, Lissauer TJ, Beard RW. Interrelationships among abnormal cardiotocograms in labor, meconium staining of the amniotic fluid, arterial cord blood pH and Apgar scores. Obstet Gynecol. 1989;74:715-21.
Frey HA, Tuuli MG, Shanks AL, Macones GA, Cahill AG. Interpreting category II fetal heart rate tracings: does meconium matter? AmJ Obs Gynecol. 2014;211:644-8.

Auteurs

Philip J Steer (PJ)

Academic Department of Obstetrics and Gynaecology, Chelsea and Westminster Hospital, London, UK.

Christopher W H Yau (CWH)

Royal College of Obstetricians and Gynaecologists, London, UK.

Maggie Blott (M)

Department of Obstetrics and Gynaecology, Royal Free London NHS Trust, London, UK.

Katherine Lattey (K)

Women's Health Department, North Bristol NHS Trust, Bristol, UK.

Millicent Nwandison (M)

Department of Obstetrics and Gynaecology, Chelsea and Westminster Hospital, London, UK.

Zeenath Uddin (Z)

Department of Women's Health, North Wing St Thomas' Hospital, London, UK.

Cathy Winter (C)

Department of Women and Children's Health, North Bristol NHS Trust, Bristol, UK.

Timothy Draycott (T)

RCOG Vice President for Clinical Quality, Royal College of Obstetricians & Gynaecologists (RCOG), London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH